JPRN-UMIN000010468
已完成
未知
Effect of alogliptin on diavetic vascular complication - Effect of alogliptin on diavetic vascular complication
Alogliptin study group0 个研究点目标入组 50 人2013年7月1日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Type 2 diabetes
- 发起方
- Alogliptin study group
- 入组人数
- 50
- 状态
- 已完成
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- 未提供
排除标准
- •1\) insulin therapy 2\)started angiotensin converting enzyme inhibitor, angiotensin receptor blocker, statin, pioglitazon within three monthes 3\) pregnancy
结局指标
主要结局
未指定
相似试验
已完成
不适用
Effect of alogliptin on endothelial dysfunction induced by postprandial hypelipidemiaJPRN-UMIN000008296Department of Cardiovascular Medicin,Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama30
已完成
不适用
Effect of alogliptin on endothelial dysfunction induced by hyperlipidemiahaelthy subjects patients wiht coronary artery disease subjects wiht metabolic symdromeJPRN-UMIN000008297Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences60
已完成
3 期
The effect of vildagliptin on endothelium-dependent vasodilatation. A double blind, cross-over study in type 2 diabetes mellitus.endothelial functionEndothelium-dependent vasodilatation1001265310003216NL-OMON32871niversitair Medisch Centrum Sint Radboud16
进行中（未招募）
1 期
The effect of vildagliptin on endothelium-dependent vasodilatation. A double blind, cross-over study in type 2 diabetes. - Vildagliptin and vasodilatatioThe effect of vildagliptin on endothelial dysfunction in type 2 diabetes, assessed by measuring endothelium-dependent vasodilatationMedDRA version: 12.0Level: LLTClassification code 10048554Term: Endothelial dysfunctionEUCTR2009-016053-18-NLMC St Radboud16
已完成
不适用
Effect of sitagliptin on vascular endothelial function in Type 2 diabetesType 2 diabetesJPRN-UMIN000009948Tokyo Women's Medical University50